The dysregulated PERK pathway has been recapitulated in AD mice models that develop β-amyloidosis [123,124,125], Tau-mediated neurodegeneration [126,127], and in SAD genetic risk factor APOEε4 mice models [128] (Figure 2 and Table 1). Here, MAPT is linked to Alzheimer disease.